Loading this committee’s profile from its FEC filings.
Where They Stand is a nonpartisan guide to everyone running for Congress: their money, their own words and how incumbents voted. Find your ballot →
Loading this committee’s profile from its FEC filings.
Where They Stand is a nonpartisan guide to everyone running for Congress: their money, their own words and how incumbents voted. Find your ballot →
PACs › PAC (nonqualified) › 2025–2026
Drug makers & biotechDrug and biotech companies, with their PACs and trade groups. Pharmacies and distributors are under Other health companies.Business › HealthPlaced by our rules or a model’s suggestion, and not yet checked by a person. The money still counts here; a person may move it.
93% of its money came through Zeneca Inc. PAC, placed under Drug makers & biotech. See where the money traces to
PAC (nonqualified)Lobbyist/registrant PACTrade associationCambridge, MassachusettsActive
FEC filings through Oct 14, 2026 · FEC bulk filing data · committee C00380733 · files quarterly
No published list of positions
Each part reads different filings, so counts and totals can differ.
Direct PAC contributions and independent expenditures explicitly reported as support, by the party of the candidate they went to.
| Party of the candidate | Candidates | Direct | Independent | Amount | Share |
|---|---|---|---|---|---|
| Democratic | 6 | $15,000 | $0 | $15,000 | 81% |
| Republican | 1 | $3,500 | $0 | $3,500 | 19% |
| Shown support | 7 | $18,500 | $0 | $18,500 | 100% |
Contributions are reported money, not endorsements; a PAC giving to both parties is common.
Every contribution on line 23 of the committee’s own Schedule B, which is the filing its summary totals are built from. That line covers federal candidates, party committees and other political committees alike, so a super PAC funding other super PACs appears here rather than under candidate giving.
| Recipient | Count | Amount |
|---|---|---|
| Democratic candidates | 6 | $15K · 64% |
| Republican candidates | 1 | $3.5K · 15% |
| Democratic party committees | 1 | $5K · 21% |
| All recipients | 8 | $23.5K |
| State | Candidates | Amount |
|---|---|---|
| Massachusetts | 5 | $13K |
| Maine | 1 | $3.5K |
| Florida | 1 | $2K |
Bars drawn to $5K, the largest gift total here. 2025–2026 filings.
Candidate contribution rows come from candidate committee Schedule A filings, the same rows the party chart above counts.
Money moving between this committee and other committees, matched on FEC committee ID rather than the name each filing was typed under. Both sides exclude memo entries. The figures here count each committee once, from the itemized transfers read for this section, so they will not match the payment counts under Who this PAC gave to.
Committees that reported giving to this one on their own Schedule A filings, grouped by the giver’s committee ID.
| Name | Amount |
|---|---|
| PAC (qualified) · Connected to ZENECA INC. · 2 payments | $10K |
$10K from 1 committee, counting every itemized receipt this cycle.
Disbursements this committee itemized to another committee: candidate contributions, party transfers and payments alike, not contributions only.
| Name | Amount |
|---|---|
| Party committee (qualified) · Connected to DEMOCRATIC GRASSROOTS VICTORY FUND · 1 payment | $5K |
| House campaign committee · Connected to NEAL VICTORY FUND · 2 payments | $3.5K |
| House campaign committee · 2 payments |
Tap a row with to see who gave.
The largest of the committees is listed. Counted from the givers' own filings and this committee's lines for them, whichever is larger, which can run above the total this committee reports.
Total reported receipts $10,000
Every dollar the committee reported receiving this cycle, split by the source the FEC filing attributes it to. FEC filings through Oct 14, 2026.
30% to named individuals, 1.1% to organizations, 69% not itemized.
| Name | Amount |
|---|---|
| 69% | $6,864 |
| Person · Executive PSS Specialty Care, Astrazeneca · Brookfield, WI · 1.3% | $134 |
| Person · Senior Vice President Market Access, Astrazeneca · Gaithersburg, MD · 1.2% | $117 |
| Person · EVP Global OPERATIONS&IT Chief Sustain, Astrazeneca · Gaithersburg, MD · 1.2% | $117 |
| Person · EVP Oncology Business, Astrazeneca · Gaithersburg, MD · 1.2% | $117 |
| Person · Executive PSS Advanced Specialty Care, Astrazeneca · Louisville, KY · 1.2% | $116 |
| Organization · 1.1% | $107 |
| Person · SVP, US President, Astrazeneca Pharmaceuticals L.P. · Wilmington, DE · 1% | $100 |
| Person · VP US Corporate Affairs, Astrazeneca · Washington, DC · 1% | $99 |
| Person · North America CFO, Astrazeneca · Wilmington, DE · 0.9% | $95 |
| Name | Amount |
|---|---|
| Person · Executive Director Marketing LOKELMA&Z, Astrazeneca · Wilmington, DE · 0.9% | $95 |
| Person · VP Global Commercial OPCSK9I, Astrazeneca · Wilmington, DE · 0.9% | $93 |
| Person · SVP Pharmaceutical TECHNOLOGY&DEVELOPM, Astrazeneca · Gaithersburg, MD · 0.9% | $92 |
| Person · Chief Human Resources Officer, Chief C, Astrazeneca Pharmaceuticals L.P. · Wilmington, DE · 0.9% | $89 |
| Person · SVP, Chief Digital Officer and CIO, Astrazeneca Pharmaceuticals L.P. · Gaithersburg, MD · 0.9% | $86 |
| Person · Executive Director, Market Access Stra, Astrazeneca Pharmaceuticals L.P. · Wilmington, DE · 0.8% | $83 |
| Person · VP Commercial and GFH Baxdrostat, Astrazeneca Pharmaceuticals L.P. · Wilmington, DE · 0.8% | $83 |
20 smaller sources, $727 in all (7.3%), are not listed.
Each committee that gave is followed to where its own money came from, in proportion to what it received: a committee that got half its money from one person is counted as passing half of what it gave on to that person. Each channel shows the committee the money came through and its place in the money tree. It shows who stood behind the money, not what that money was for, and an organization that need not name its donors ends the trail. It stops at a person, an organization, a committee with nothing on file here, or 3committees deep. A person who gave by more than one route appears under each, a name filed two ways may appear twice, and a person's job and city are as they filed them. "Also behind" counts the other groups, among those that moved $100,000 or more into races, in which $100,000 or more traces to the same person, other than those this money came through or went on to.
Tap a row with to see who was paid.
Total reported disbursements $24,000
Every dollar this committee reported spending this cycle, split by the lines it reports against. Open a line to see who was actually paid on it. FEC filings through Oct 14, 2026.
Tap a row with to see what was paid for.
Total itemized disbursements $24,000
Every itemized payment the committee reported this cycle, sorted by what it said each one was for. The categories are ours; the wording they are matched against is the committee’s own. Open a category to read the filed descriptions and who was paid. FEC filings through Oct 14, 2026.
All 13 itemized payments filed this cycle. Spending below the itemization threshold is not filed line by line.
| Name | Amount |
|---|---|
| 1 payment · 21% of all spending |
$24K spent from Jan 2025 to Oct 2026. Most in one report: $9K, Jan 1 – Jun 30, 2025.
The running total of what the committee’s FEC reports say it spent, independent expenditures included, with a point at the end of each report. The line is straight between reports because a report gives one total for its whole period.
Transfers, refunds, and everything else the committee itemized outside candidate giving. 1 payments totaling $500.
Besides giving through its PAC, Massachusetts Biotechnology Council pays lobbyists to press Congress and federal agencies. Each quarter it, or a firm it hires, files a public report under the Lobbying Disclosure Act saying which topics it worked on, what it spent, and whom it contacted. This is what those reports say.
Each report files its work under official topics. The bar shows how often each topic came up across the reports; open one to read what was filed under it. Naming a bill says the organization lobbied on it, not which side it took.
The organization’s own reports give its total lobbying costs, including any firms it hired; each firm reports what this client paid it.
Matched by name: these reports are filed for “MASSACHUSETTS BIOTECHNOLOGY COUNCIL”, found by searching “MASSACHUSETTS BIOTECHNOLOGY COUNCIL”. Lobbying and FEC records share no ID, so an organization that lobbies under another name is missed. Source: LDA.gov, accessed Nov 9, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Massachusetts Biotechnology Council Inc. Federal PAC is registered with the Federal Election Commission as a PAC (nonqualified). It is a lobbyist/registrant PAC. Official FEC summary: Federal Election Commission committee record.
No pages quoted
No approved organization identity yet
| $3.5K |
| Senate campaign committee · Connected to COLLINS VICTORY COMMITTEE · 2 payments | $3.5K |
| House campaign committee · Connected to CLARK TRAHAN PRESSLEY VICTORY FUND · 2 payments | $3K |
| House campaign committee · Connected to JAKE AUCHINCLOSS VICTORY FUND · 1 payment | $2K |
| House campaign committee · 1 payment | $2K |
| Senate campaign committee · Connected to MARKEY VICTORY FUND · 1 payment | $1K |
$23.5K across 8 recipient committees, or 98% of everything this committee reports spending.
Built from FEC Schedule A and Schedule B filings for the selected cycle. A committee only appears here if the money was itemized under its FEC committee ID.
| $78 |
| Person · Executive Director National Channel, Astrazeneca · Austin, TX · 0.8% | $77 |
| Person · Senior Director Immuno-Oncology Cancer, Astrazeneca · Wolcott, CO · 0.7% | $67 |
| Person · Assistant General Counsel Commercial, Astrazeneca · Gaithersburg, MD · 0.7% | $66 |
| Person · Executive Director US Patient Support&, Astrazeneca · Gaithersburg, MD · 0.6% | $61 |
| Person · Head of State Government Affairs, Astrazeneca Pharmaceuticals L.P. · Stratham, NH · 0.6% | $60 |
| Person · Executive Director US Evidence, Astrazeneca · Wilmington, DE · 0.6% | $58 |
| Person · Head of Corporate Affairs US Federal G, Astrazeneca · Washington, DC · 0.6% | $56 |
| Person · Executive PSS Primary Care, Astrazeneca · Jacksonville, FL · 0.6% | $56 |
| Person · Access Contracting Director, Astrazeneca · Sapulpa, OK · 0.5% | $54 |
| Person · Senior Director GPTW HR&LEGAL Communic, Astrazeneca · Wilmington, DE · 0.5% | $53 |
| Person · Global Product Leader Baxdrostat/dapag, Astrazeneca · Gaithersburg, MD · 0.5% | $51 |
| Person · VP US Oncology Care and Access, Astrazeneca Pharmaceuticals L.P. · Gaithersburg, MD · 0.5% | $50 |
| $5,000 |
| 2 payments · 15% of all spending | $3,500 |
| 2 payments · 15% of all spending | $3,500 |
| 2 payments · 15% of all spending | $3,500 |
| 2 payments · 13% of all spending | $3,000 |
| 1 payment · 8.3% of all spending | $2,000 |
| 1 payment · 8.3% of all spending | $2,000 |
| 1 payment · 4.2% of all spending | $1,000 |
The people, firms and committees paid the most, across every kind of payment. Each share is of everything the committee reported spending this cycle, not only the itemized payments above. A payee that is itself a committee links to its own profile.